‹ ›
MYP_116714
← PREVIOUS NEXT → BACK
Basic Information
Ilamycin D
Anticancer
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antimicrobial ▸ Antibacterial
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
not Standard
7 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XXLXAXX
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0060359 VERIFIED: YES
Provenance & Taxonomy
Streptomyces atratus SCSIO ZH16 [Bacterium]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
unspecified non-canonical residue at 1,2,4,6,7
Bio-Activity Profile
Antimicrobial Antibacterial
Human cervical carcinoma HeLa
50 μM
IC50
PMID28855504 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28855504/
RECORD: Rec_0061521 VERIFIED: YES
Provenance & Taxonomy
Streptomyces atratus SCSIO ZH16 [Bacterium]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
unspecified non-canonical residue at 1,2,4,6,7
Bio-Activity Profile
Antimicrobial Antibacterial
Mycobacterium tuberculosis H37Rv
0.0098 μM
MIC
PMID28855504 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28855504/
RECORD: Rec_0065628 VERIFIED: YES
Provenance & Taxonomy
Streptomyces atratus [Bacterium]
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu
Bio-Activity Profile
Antimicrobial Anticancer
A549
13.8 μM
IC50
PaperBiosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nat Commun. 2017 Aug 30;8(1):391. doi: 10.1038/s41467-017-00419-5. PMID: 28855504. PMID28855504 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28855504/
RECORD: Rec_0066417 VERIFIED: YES
Provenance & Taxonomy
Streptomyces atratus [Bacterium]
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu
Bio-Activity Profile
Antimicrobial Anticancer
HeLa
3.3 μM
IC50
PaperBiosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nat Commun. 2017 Aug 30;8(1):391. doi: 10.1038/s41467-017-00419-5. PMID: 28855504. PMID28855504 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28855504/
RECORD: Rec_0070675 VERIFIED: YES
Provenance & Taxonomy
Streptomyces atratus [Bacterium]
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu
Bio-Activity Profile
Antimicrobial Anticancer
CNE2
6.8 μM
IC50
PaperBiosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nat Commun. 2017 Aug 30;8(1):391. doi: 10.1038/s41467-017-00419-5. PMID: 28855504. PMID28855504 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28855504/
FIRST PREV 1 ... 4 5 6 7 8 ... 36 NEXT LAST
Showing 5 records on this page · Page 6 of 36